Why the study?
Does H-FABP provide better prognostic value for mortality and sepsis-related left-ventricular dysfunction compared to troponin I in ICU patients with sepsis?
Does H-FABP provide better prognostic value for mortality and sepsis-related left-ventricular dysfunction compared to troponin I in ICU patients with sepsis?
H-FABP may serve as a superior prognostic biomarker compared to troponin I for predicting mortality and left-ventricular systolic dysfunction in patients with septic shock.
H-FABP positivity may flag sepsis-related LV dysfunction in shock; hypothesis-generating versus troponin I, needs prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sherif et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: